Androgens and androgen receptor signaling in prostate tumorigenesis.

نویسندگان

  • Ye Zhou
  • Eric C Bolton
  • Jeremy O Jones
چکیده

Androgens and androgen receptor (AR) signaling are necessary for prostate development and homeostasis. AR signaling also drives the growth of nearly all prostate cancer cells. The role of androgens and AR signaling has been well characterized in metastatic prostate cancer, where it has been shown that prostate cancer cells are exquisitely adept at maintaining functional AR signaling to drive cancer growth. As androgens and AR signaling are so intimately involved in prostate development and the proliferation of advanced prostate cancer, it stands to reason that androgens and AR are also involved in prostate cancer initiation and the early stages of cancer growth, yet little is known of this process. In this review, we summarize the current state of knowledge concerning the role of androgens and AR signaling in prostate tissue, from development to metastatic, castration-resistant prostate cancer, and use that information to suggest potential roles for androgens and AR in prostate cancer initiation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression

Inflammatory cytokines and chemokines released by macrophages in the prostate cancer microenvironment may signal via the androgen receptor (AR) to influence tumor progression. In particular, macrophages appear to promote tumorigenesis by altering the chemokine (C-C motif) ligand 4 (CCL4)/AR signaling axis. This process can be blocked by ASC-J9®, an enhancer of AR degradation. ASC-J9® also inhib...

متن کامل

Collocation of androgen receptor gene mutations in prostate cancer.

Consistent with both the development of the normal prostate gland and prostate tumorigenesis being dependent on testicular androgens, targeting the androgen-signaling axis (i.e., androgen ablation therapy) remains the predominant treatment regime for patients with metastatic prostate cancer. Although there is a very good initial response to androgen ablation, these treatments are essentially pa...

متن کامل

Pten inactivation and the emergence of androgen-independent prostate cancer.

Hormone refractory disease represents a late-stage and generally lethal event in prostate tumorigenesis. Analyses of mouse models have recently shown that the onset of hormone independence can be uncoupled from disease progression and is associated with activation of the phosphoinositide-3 kinase/Akt as well as Erk mitogen-activated protein kinase signaling pathways in the prostate epithelium, ...

متن کامل

The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer

According to the American Cancer Society approximately 242,000 new cases of prostate cancer will be reported in 2012, making it one of the most frequently diagnosed cancers in men. Moreover, with 1 in 9 men diagnosed with prostate cancer anticipated to die of the disease, prostate cancer is also the second-leading cause of cancer death in men. Although several new treatment options for men with...

متن کامل

Crosstalk between the Epidermal Growth Factor Receptor and Androgen Receptor Signaling Pathways in Prostate Cancer

Gregory CW. Crosstalk between the Epidermal Growth Factor Receptor and Androgen Receptor Signaling Pathways in Prostate Cancer. Annu Rev Biomed Sci 2009;11:T102-T113. Malignant cells are characterized by complex and often overlapping signaling pathways that modulate uncontrolled proliferation, leading to tumor growth and cancer progression. Prostate cancer is characterized by a dependence on an...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of molecular endocrinology

دوره 54 1  شماره 

صفحات  -

تاریخ انتشار 2015